Table 2.
Baseline laboratory data of stroke patients in the two groups
| With pre-existing statin use (n = 43) | Without pre-existing statin use (n = 129) | P value | |
|---|---|---|---|
| White blood cells (X103/ml) | 7.5 ± 0.4 | 7.5 ± 0.3 | 0.86 |
| Red blood cells (X106/ml) | 4.6 ± 0.1 | 4.7 ± 0.1 | 0.71 |
| Platelet counts (X104/ml) | 20.2 ± 1.1 | 21.9 ± 0.7 | 0.43 |
| Total cholesterol (mg/dl)† | 148.3 ± 4.3 | 218.8 ± 6.5 | < 0.0001 |
| LDL-cholesterol (mg/dl)† | 83.0 ± 3.7 | 142.9 ± 5.1 | < 0.0001 |
| HDL-cholesterol (mg/dl)† | 40.3 ± 1.6 | 42.8 ± 1.5 | 0.27 |
| Triglyceride (mg/dl) | 125.3 ± 8.3 | 176.3 ± 14.7 | 0.04 |
| HbA1c (%) | 7.3 ± 0.3 | 7.1 ± 0.3 | 0.43 |
| APTT (second) | 28.0 ± 0.5 | 27.9 ± 0.4 | 0.91 |
| PT (second) | 10.2 ± 0.1 | 10.1 ± 0.1 | 0.37 |
| Systolic BP (mmHg) | 138.7 ± 2.4 | 146.6 ± 2.4 | 0.13 |
| Diastolic BP (mmHg) | 80.1 ± 1.3 | 85.2 ± 1.6 | 0.10 |
| CD62P (%)† | 2.2 ± 0.6 | 3.9 ± 0.5 | 0.01 |
| CD63 (%)† | 1.2 ± 0.2 | 1.8 ± 0.5 | 0.03 |
APTT, activated partial thromboplastin time; BP, blood pressure; HbA1c, hemoglobin A1c; HDL, high density lipoprotein; LDL, low density lipoprotein; PT, prothrombin time.
† The data was expressed as primitive data, and the P value was obtained from those primitive data that were logarithmically transformed to improved normality and compared by independent -t test.